Zobrazeno 1 - 9
of 9
pro vyhledávání: '"drugs pricing"'
Autor:
Federico Villa, Aurora Di Filippo, Andrea Pierantozzi, Armando Genazzani, Antonio Addis, Gianluca Trifirò, Agnese Cangini, Giovanni Tafuri, Daniela Settesoldi, Francesco Trotta
Publikováno v:
Frontiers in Medicine, Vol 9 (2022)
IntroductionIt is well acknowledged that the price of orphan drugs is normally higher than that resulting from the value-based pricing. A correlation between the cost of therapy for orphan drugs and the epidemiology (prevalence and incidence) of the
Externí odkaz:
https://doaj.org/article/afb495ca257e4a7d93148e83fe67162f
Autor:
Francesco Trotta, Federico Villa, Armando A. Genazzani, Simone Ghislandi, Elisabetta Listorti, Claudio Jommi, Agnese Cangini
Publikováno v:
Orphanet Journal of Rare Diseases, Vol 16, Iss 1, Pp 1-10 (2021)
Orphanet Journal of Rare Diseases
Orphanet Journal of Rare Diseases
Background and aim Evidence on determinants of prices for orphan medicines is scarce and not available for Italy. The aim of this paper is to provide an evidence on variables affecting the annual treatment cost of orphan drugs in Italy, testing the h
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::02d2a4b6f73251816704b8bce79226d3
http://hdl.handle.net/11565/4047101
http://hdl.handle.net/11565/4047101
Autor:
Moorkens, Evelien, Godman, Brian, Huys, Isabelle, Hoxha, Iris, Malaj, Admir, Keuerleber, Simon, Stockinger, Silvia, Mörtenhuber, Sarah, Dimitrova, Maria, Tachkov, Konstantin, Vončina, Luka, Palčevski, Vera Vlahović, Achniotou, Gnosia, Slabý, Juraj, Popelková, Leona, Kohoutová, Kateřina, Bartels, Dorthe, Laius, Ott, Martikainen, Jaana E., Selke, Gisbert W., Kourafalos, Vasileios, Magnússon, Einar, Einarsdóttir, Rannveig, Adams, Roisín, Joppi, Roberta, Allocati, Eleonora, Jakupi, Arianit, Viksna, Anita, Greičiūtė-Kuprijanov, Ieva, Vella Bonanno, Patricia, Suttorp, Vincent, Melien, Øyvind, Plisko, Robert, Mardare, Ileana, Meshkov, Dmitry, Novakovic, Tanja, Fürst, Jurij, Zara, Corinne, Marković-Peković, Vanda, Grubiša, Nataša, Befrits, Gustaf, Puckett, Robert, Vulto, Arnold G.
Background: From October 2018, adalimumab biosimilars could enter the European market. However, in some countries, such as Netherlands, high discounts reported for the originator product may have influenced biosimilar entry. Objectives: The aim of th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______3549::3017ab381eabe94e09d7e7471b42582b
https://www.um.edu.mt/library/oar/handle/123456789/94432
https://www.um.edu.mt/library/oar/handle/123456789/94432
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
В условиях глобализации фармацевтические фирмы и аптеки должны в совершенстве владеть существующими методиками ценообразования в цел
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ce80986e274a8cb0b30aa7728a46a37e
Autor:
Gianfrate Fabrizio
Publikováno v:
L'industria. (1):85-121
This paper would like to give a contribution to the discussion on which policies and rules should be adopted in order to relaunch the pharmaceutical sector in Italy. Due to its intrinsic features, social value and being one of the most regulated and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_______645::069fcb83e38f192ee7e4439f4babcf58
https://www.rivisteweb.it/download/article/10.1430/24256
https://www.rivisteweb.it/download/article/10.1430/24256
Autor:
Novotná, Ivana
This bachelor's degree thesis focuses on the trajectory of drugs from basic research to the consumer and after its succesful completion, the consumer can use efficient and safe drugs. The purpose of this thesis is to describe the trajectory of drugs
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2186::4886fcb6dfb5b25fe843fa041d325dce
http://www.nusl.cz/ntk/nusl-73108
http://www.nusl.cz/ntk/nusl-73108
Autor:
Anna Merino-Castelló
This article analyses the impact of the reference price system on the price-setting strategies of the pharmaceutical firms and on the level of generic usage. This model is the first to take explicitly into account the impact of the reference price me
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e7c4237bf9f47879c41bd710b75ef7c6
https://econ-papers.upf.edu/papers/524.pdf
https://econ-papers.upf.edu/papers/524.pdf
Reports on a survey of eligible entities—including disproportionate share hospitals, federally qualified health centers, community health centers, migrant health centers, and others—on their understanding of the Public Health Service dr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_______645::5eb0a75b12d8d2407805e45339e6e931
https://www.mathematica-mpr.com/-/media/publications/pdfs/health/phs_drug_pricing.pdf
https://www.mathematica-mpr.com/-/media/publications/pdfs/health/phs_drug_pricing.pdf